Editorial: Cardiometabolic diseases in postmenopausal women

Editorial: Cardiometabolic diseases in postmenopausal women

Saved in:

Bibliographic Details
Main Authors:	Aleksandra Klisic, Rasheed Ahmad, Bledar Daka, Sardar Sindhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-11-01
Series:	Frontiers in Endocrinology
Subjects:	cardiometabolic disorders postmenopausal women inflammation oxidative stress MAFLD (metabolic dysfunction-associated fatty liver disease) osteoporosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1514913/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Metabolic associated fatty liver disease (MAFLD) in childhood: a new challenge
by: Anna Di Sessa
Published: (2025-02-01)

Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis
by: Farah Abdelhameed, et al.
Published: (2025-04-01)

The application of FRAX values to determine the distribution of risk factors for Osteoporosis in Postmenopausal women
by: Tri Hari Irfani
Published: (2016-03-01)

Cardiometabolic index is a novel predictor for osteoporosis in type 2 diabetes mellitus patients with MAFLD: a cross-sectional study
by: Yangyang Zhang, et al.
Published: (2025-08-01)

The association between total, animal, and plant protein intake and metabolic dysfunction-associated fatty liver disease in overweight and obese children and adolescents
by: Ali Nikparast, et al.
Published: (2025-05-01)

Risk factors of metabolic dysfunction-associated fatty liver disease in Chinese nurses: an ambispective cohort study
by: Jing Wang, et al.
Published: (2025-08-01)

The effects of kefir drink on liver aminotransferases and metabolic indicators in patients with nonalcoholic fatty liver disease: a randomized controlled trial
by: Farzaneh Mohammadi, et al.
Published: (2025-01-01)

Machine Learning-Based Non-Invasive Prediction of Metabolic Dysfunction-Associated Steatohepatitis in Obese Patients: A Retrospective Study
by: Jie Chen, et al.
Published: (2025-04-01)

Association between cardiometabolic index and postmenopausal stress urinary incontinence: a cross-sectional study from NHANES 2013 to 2018
by: Ting Yin, et al.
Published: (2025-05-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

RISK ASSESSMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Z. Shukerova
Published: (2020-12-01)

Association of Serum Selenium with Clinical Features and Inflammatory and Oxidative Stress Markers in Iranian Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease—A Cross-Sectional Study
by: Abbas Pishdadian, et al.
Published: (2025-06-01)

Prevalence and influencing factors of MAFLD among residents aged 65 years and older in a district of Wuhan
by: Wen-Shuang WEI, et al.
Published: (2022-04-01)

Enzyme and lipid markers in relation to cardiovascular risk in postmenopausal women
by: Klisić Aleksandra, et al.
Published: (2025-01-01)

Ovariectomy-induced bone loss through inappropriate inflammatory response: an osteoimmunological perspective on postmenopausal osteoporosis
by: Lilika Higuchi, et al.
Published: (2025-05-01)

Global burden trends and forecasts for MAFLD in adolescents and young adults from 1990 to 2021
by: Shiying Ruan, et al.
Published: (2025-04-01)

Cardiometabolic risk in non-diabetic metabolic dysfunction-associated steatotic liver disease (MAFLD) patients: insights from the triglyceride-glucose, plasma atherogenic, and cardiometabolic index
by: Sedat Ciftel, et al.
Published: (2024-07-01)

Gynoid lean muscle mass as mediator between menarche age, hand grip and bone mineral density in postmenopausal women
by: Miyang Xu, et al.
Published: (2025-05-01)

Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value
by: Luyu Wang, et al.
Published: (2025-07-01)

Arterial stiffness, high fasting glucose, and fatty liver as risk factors for visceral obesity in middle-aged Chinese individuals: a cross-sectional study
by: Hajime Nawata, et al.
Published: (2025-05-01)

The Management of Cardiometabolic Risk in MAFLD: Therapeutic Strategies to Modulate Deranged Metabolism and Cholesterol Levels
by: Annalisa Pezzoli, et al.
Published: (2025-02-01)

KRT23 as a Potential Target for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): Evidence From Bioinformatics Analysis, Human Gene Polymorphism and Animal Experiments
by: Hao Y, et al.
Published: (2025-06-01)

MASLD vs. MAFLD. A narrative review
by: Amedeo Lonardo, et al.
Published: (2025-08-01)

Quality use of medicines: The postmenopausal woman with osteoporosis
by: Andy Gray, et al.
Published: (2003-05-01)

Diagnostic accuracy of Fatty Liver Index (FLI) for detecting Metabolic Associated Fatty Liver Disease (MAFLD) in adults attending a tertiary care hospital, a cross-sectional study
by: Roshni Vamja, et al.
Published: (2024-12-01)

Evaluation of relationship between SPON1 gene and genetic susceptibility of postmenopausal osteoporosis
by: Wenlong Ma, et al.
Published: (2020-01-01)

Association between non-skimmed milk consumption and metabolic dysfunction-associated fatty liver disease in US adults: insights from NHANES data
by: Futao Wu, et al.
Published: (2025-04-01)

Radiomics based on lumbar CT to identify high-risk patients for OVCF in postmenopausal women
by: Qingsong Yu, et al.
Published: (2025-06-01)

Serum interleukin-17 expression in postmenopausal women and its relation to osteoporosis and risk of fractures
by: Samar G. Soliman, et al.
Published: (2025-01-01)

Estimation of Some Biomarkers Related to Bone Turnover in Iraqi Women
by: Wafaa Raji Alfatlawi
Published: (2025-04-01)

Understanding Why Metabolic-Dysfunction-Associated Steatohepatitis Lags Behind Hepatitis C in Therapeutic Development and Treatment Advances
by: Caesar Ferrari, et al.
Published: (2024-10-01)

The association between lifelines diet score and metabolic associated fatty liver disease: a case–control study
by: Thanyaporn Direksunthorn, et al.
Published: (2025-05-01)

Unravelling the gut-liver axis: The role of gut microbiota-mitochondria interactions in the pathogenesis and management of metabolic-associated fatty liver disease (MAFLD)
by: Binzhi Zhang, et al.
Published: (2025-03-01)

Fat and Cardiometabolic Risk Burden
by: Dyah Purnamasari
Published: (2017-08-01)

Fat and Cardiometabolic Risk Burden
by: Dyah Purnamasari
Published: (2017-08-01)

Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study
by: Ziping Song, et al.
Published: (2025-04-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Association between metabolic-associated fatty liver disease and risk of cardiometabolic multimorbidity: a disease trajectory analysis in UK Biobank
by: Yaqian Gao, et al.
Published: (2025-06-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Associations between intake of different types of vegetables and metabolic dysfunction-associated fatty liver disease: a population-based study
by: Chong Liu, et al.
Published: (2025-01-01)